Table 1. Laboratory findings in the patient along time.
| Age (years) | 13 | 14 | 16 | 17 | Reference values |
| Serum IgG (mg/dl) | 1190 | 1270 | 1130 | 1040 | 984–1544 |
| Serum IgA (mg/dl) | 290 | 247 | 112 | 144 | 112–252 |
| Serum IgM (mg/dl) | 196 | 80 | 100 | 91 | 82–220 |
| Anti-TT Ab (UI/ml) * | 0.5 | 0.8 | ND † | ND | >0.1 |
| Anti- pnemococcus Ab (mg/dl) | 88 | 270 | 216 | 139 | >113 ‡ |
| Anti-measles virus Ab | + | ND | ND | ND | |
| Anti-HIV Ab | − | − | ND | ND | |
| Granulocyte percentage in whole blood | 72 | 54 | 58 | 49 | 40–80% |
| Monocyte percentage in PBMCs (cells/mm3) | 7 (168) | 8 (156) | 8 (208) | 8 (557) | 4–13% |
| T cell percentage in PBMCs (cells/mm3) | |||||
| CD3+ | 57 (1368) | 66 (1289) | 66 (1719) | 58 (4041) | 65–85% |
| CD4+ | 32 (768) | 39 (729) | 36 (936) | 35 (2450) | 36–46% |
| CD8+ | 19 (456) | 23 (430) | 25 (650) | 20 (1400) | 19–40% |
| B cell percentage in PBMCs (cells/mm3) | |||||
| CD20+ | 28 (672) | 24 (467) | 20 (520) | 26 (1812) | 7–23% |
| Proliferative response (cpm) | |||||
| PHA | 40000 | 115000 | ND | ND | 74.000–135.000 |
| ConA | 79000 | 101000 | ND | ND | 54.000–104.000 |
| Anti-CD3 | 46000 | 180000 | ND | ND | 55.000–91.000 |
| PMA + Ionomycin | 69000 | 275000 | ND | ND | 61.000–149.000 |
| DTH | N § | ND | ND | ND | |
*
TT: Tetanus toxoid; †ND: not determined; ‡As established by the Argentinean Society of Pediatrics; §N: normal.